Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. - Wikidata - awgldk - TriplyDB

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.

http://www.wikidata.org/entity/Q36183810

about

Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges Expanding the Repertoire of Biomarkers for Alzheimer's Disease: Targeted and Non-targeted Approaches Unfolded Protein Response and Macroautophagy in Alzheimer's, Parkinson's and Prion Diseases Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology Fluid Biomarkers in Clinical Trials of Alzheimer's Disease Therapeutics The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception Ageing, neurodegeneration and brain rejuvenation Neuroinflammation in Alzheimer's disease Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers A Subset of Cerebrospinal Fluid Proteins from a Multi-Analyte Panel Associated with Brain Atrophy, Disease Classification and Prediction in Alzheimer's Disease Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers White matter abnormalities associated with Alzheimer's disease and mild cognitive impairment: a critical review of MRI studies.2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Relationship between plasma analytes and SPARE-AD defined brain atrophy patterns in ADNI Phosphorylated tau-Aβ42 ratio as a continuous trait for biomarker discovery for early-stage Alzheimer's disease in multiplex immunoassay panels of cerebrospinal fluid.Genomic convergence and network analysis approach to identify candidate genes in Alzheimer's disease.Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort.Low plasma leptin in cognitively impaired ADNI subjects: gender differences and diagnostic and therapeutic potential.Circulating biomarkers that predict incident dementia.Is Alzheimer's disease a systemic disease?The future of blood-based biomarkers for Alzheimer's disease.A platelet protein biochip rapidly detects an Alzheimer's disease-specific phenotype Plasma proteins predict conversion to dementia from prodromal disease Influence of genetic variation on plasma protein levels in older adults using a multi-analyte panel.Circulating miRNA biomarkers for Alzheimer's disease Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: a pilot-study Parallel age-associated changes in brain and plasma neuronal pentraxin receptor levels in a transgenic APP/PS1 rat model of Alzheimer's disease.Meta-analysis of peripheral blood apolipoprotein E levels in Alzheimer's disease.Validation of a serum screen for Alzheimer's disease across assay platforms, species, and tissues.The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link?Platelet dysfunction in hypercholesterolemia mice, two Alzheimer's disease mouse models and in human patients with Alzheimer's disease.Central Nervous System and Peripheral Inflammatory Processes in Alzheimer's Disease: Biomarker Profiling Approach.A novel multi-tissue RNA diagnostic of healthy ageing relates to cognitive health status.Association of Pancreatic Polypeptide with Mild Cognitive Impairment Varies by APOE ε4 Allele.Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study.Multiplex analyte assays to characterize different dementias: brain inflammatory cytokines in poststroke and other dementias The link between C-reactive protein and Alzheimer's disease among Mexican Americans.Biomarkers of Alzheimer's disease among Mexican Americans.Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain.

P2860

Q24289435-3A6B06EA-39EF-4B76-A2DF-0F20FD0D9CD0 Q24289443-4BF7E6E5-422B-4287-9C87-9AD3EB8E0014 Q26770708-FB079CC1-214C-4916-A46F-2F04EA2833B9 Q26773443-49DB438B-B798-4082-A8D0-A350AE8B0093 Q26774743-664BB3C4-F22E-42C9-B8A9-0D6DA4C976EF Q26784569-2CDA4AB7-AFE8-4867-BAC0-66CB59D8816A Q27006831-2814794C-BA3C-4767-8492-525D55A143A7 Q28071590-3DB6FB97-5F1C-4195-A86F-3895D0390169 Q28259238-1E5FF6F3-99D2-4A1D-9EC5-79FA78D96F49 Q28542010-A4F936F0-8139-4848-9359-CA82A207A0C2 Q28547333-80FBB0CD-A82D-4053-BAEE-519835EF36DF Q29620245-7DFF30D7-8E55-4F6C-98A5-79BD6C927AF1 Q30620060-7AF130E8-BD2F-4AC1-AD6C-29C0765D72BB Q30971403-36779E08-3671-4422-B2B3-ECB5578A017F Q31110973-C3978666-895C-40E8-A9BC-C716404E6F62 Q33554802-C0C33BEB-3A91-4CE9-817A-0292AFA48E1F Q33637672-19CC715A-1B55-4C31-954C-0DA05BFDEB3A Q33652456-0B8E47B7-31F9-4DCB-80C1-9A3796F11D65 Q33692408-922B7620-9D13-4D69-B062-4BE38FF2B170 Q33752058-A6FCB900-1389-4D94-AE3E-404FB4FC5F9F Q34019193-5115832C-F4A2-4C9C-A6A1-DAE2B853AE74 Q34026317-354D58B0-B016-4594-86D6-F9C8F79B2CB4 Q34363475-339C7D70-5921-4C12-B202-72F99CF0C40B Q34556953-C501D05B-D10E-443C-ABDC-A18793ECDBFA Q34875967-2050A3E3-367C-4A95-856E-DE8E13A4025A Q34904013-F2195B0E-8B34-4CE0-9833-37E1DCC225F0 Q35034827-89B827BF-8541-4D19-9D24-1B5AC402D4DB Q35071220-D3AF8804-8059-4398-A5F4-6A51C89422C8 Q35099780-1671DDEB-22C3-4A53-8DD5-69C895A0B787 Q35456060-4AC36714-9926-4E6F-8A56-B357E87BF1CE Q35502548-AF7B0FBF-0244-4FB1-B1C0-9B75872011C7 Q35804607-EC88E417-FBAD-4BFF-8290-FC4887CE8064 Q35990600-5546B635-0E2D-4621-81B3-4B3FCE434D6F Q36032418-378F6A4A-A45F-45A4-A377-AEACA2D8E0D3 Q36033650-DF00A8D8-E0F3-490C-B1C5-1CDFE420B289 Q36353787-4DAE1184-CAE5-45D5-B6FF-17902D7991EA Q36595660-6CEB25BD-E167-458D-8B42-710DA06674E5 Q36716958-786ACFE6-F437-458E-8E00-8A8F5542333D Q36716970-8160F61B-6BC1-44F3-8460-2EA208F57715 Q36836566-C185DBC7-87E2-4AAA-80A8-9558D5BF2EDB

P2860

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.

http://www.wikidata.org/entity/Q36183810

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.

@ast

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.

@en

type

label

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.

@ast

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.

@en

prefLabel

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.

@ast

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.

@en

P1433

Q36183810-ABBEE523-D303-46C4-A9AF-0E165FD87184

P1476

Q36183810-473FDE87-A21E-423C-9088-A7B435F8FFC9

P2093

Q36183810-084B3BE7-B457-426B-A8B9-9BAF2D3D7592

Q36183810-0B49E7DB-74EB-4507-A4F6-9E18CFA29DC9

Q36183810-41112760-24C5-47CA-9792-70D962A4E058

Q36183810-42C7BB4B-C019-4A55-8119-84C10874D45D

Q36183810-5201F0EC-10F1-441D-8A86-F4ABDC5C1324

Q36183810-61156B8B-B4FB-4F9F-9065-03A7D1159BEC

Q36183810-61443ADB-5998-4FF8-A416-8496081D7D66

Q36183810-677096CA-3874-46E0-BBBC-8E1001D14E00

Q36183810-6D30E70C-395B-420A-A929-C246A9397163

Q36183810-6E765B73-5065-4812-9BCE-7782DE1F937A

P2860

Q36183810-029C456E-503B-4524-831E-82204830294F

Q36183810-03BF95B2-082A-476F-AF85-12A1A9C723C4

Q36183810-050A3419-0342-4F9A-B661-C4EAF49DF7DA

Q36183810-053AEB3F-E507-4153-AF31-34117312EA41

Q36183810-08A6AD41-BAE9-48F8-A614-7BD93CD112BD

Q36183810-0ABDC040-76C8-4F2D-877C-6B01F4440A95

Q36183810-0FE5CA5C-7257-4261-B07C-CD18C648B447

Q36183810-1E111D58-5F90-4D1A-8A21-776218A04F32

Q36183810-2550D87C-74EC-4CAD-AF3B-EB067AFEA7C2

Q36183810-25824679-D073-47C1-A5A4-D76DC90C5F05

P304

Q36183810-341C3845-5E48-4795-BB80-C1EB7453E9DD

P31

Q36183810-BE34A739-2B34-4012-B537-DBCC747D8E0A

P356

Q36183810-7A32AECB-0BB3-46C1-A91E-7F4E93620800

P407

Q36183810-7858CA79-32A6-4595-A7F7-F3AA84E3F0A2

P433

Q36183810-A03AD507-2710-40B2-9B64-86600C48BEDE

P478

Q36183810-3A4E4D7D-428F-4556-AB10-477082E937CB

P50

Q36183810-0CDAEBC4-9A55-4DD5-AA0A-A583C2AA5A67

Q36183810-19937E17-0B47-43F7-BE70-14ABCA6E0269

Q36183810-3797B96D-9AD8-4C82-B65E-1620EE811710

Q36183810-392CC920-551E-4BF1-A839-E2A17D77B5B3

Q36183810-3A408932-B080-45E0-9812-EC1D5F9BEE26

Q36183810-5BD425CC-8C39-4D95-AC38-59A064E24B4E

Q36183810-ECFA7CB5-9912-4E26-B3A6-3AFE8B3EE38F

Q36183810-F5BB500A-BA33-4C40-9C00-4F209BF11D17

Q36183810-F9C5B0FE-36E0-45A2-9AFA-CF02B5193FC7

P577

Q36183810-D3485F82-3A2B-4C23-8416-402D125F2B1D

P5875

Q36183810-DCBD429E-2A5A-47B5-BD2B-7BAADA8991C0

P698

Q36183810-F5A1A840-A176-4301-BE1C-CBF2BE664C69

P921

Q36183810-335F919D-E340-4E34-8A3A-1D4C5F141E9D

P932

Q36183810-FA80B920-54C0-4A12-B723-398C5336190B

P356

WNL.0B013E318266FA70

P1433

P1476

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.

@en

P2093

Alice Chen-Plotkin

http://www.w3.org/2001/XMLSchema#string

Chengjie Xiong

http://www.w3.org/2001/XMLSchema#string

Christopher M Clark

http://www.w3.org/2001/XMLSchema#string

Eve Pickering

http://www.w3.org/2001/XMLSchema#string

Frank Swenson

http://www.w3.org/2001/XMLSchema#string

Holly Soares

http://www.w3.org/2001/XMLSchema#string

Howard I Hurtig

http://www.w3.org/2001/XMLSchema#string

Lauren Elman

http://www.w3.org/2001/XMLSchema#string

Leo McCluskey

http://www.w3.org/2001/XMLSchema#string

Leslie M Shaw

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of candidate IgG biomarkers for Alzheimer's disease via combinatorial library screening

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Mild cognitive impairment: clinical characterization and outcome

A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

Diagnosis of multiple cancer types by shrunken centroids of gene expression

The Clinical Dementia Rating (CDR): current version and scoring rules

P304

897-905

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0B013E318266FA70

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P50

Alzheimer's Disease Neuroimaging Initiative

David M. Holtzman

John Q. Trojanowski

Steven E. Arnold

Murray Grossman

Andrew Siderowf

Jason Karlawish

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230600101

http://www.w3.org/2001/XMLSchema#string

P698

22855860

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3425844

http://www.w3.org/2001/XMLSchema#string